Navigation Links
'Sharing Miracles' Television Program to Feature North Carolina State Women's Basketball Coach Kay Yow
Date:2/1/2008

WASHINGTON, Feb. 1 /PRNewswire-USNewswire/ -- This month, Sharing Miracles -- a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients -- will feature North Carolina State University women's basketball coach Kay Yow, the fifth winningest active women's coach in NCAA Division I.

Coach Yow has achieved a tremendous legacy as a women's basketball coach, guiding the Wolfpack to four ACC tournament titles, 11 trips to the Sweet 16, and one trip to the Final Four, and also coaching the 1988 Olympic gold-medal winning U.S. team. She is a member of the Women's Basketball Hall of Fame and, in 2007, was honored with the inaugural Jimmy V ESPY Award for perseverance.

Though Coach Yow is best known for her battles on the court, Sharing Miracles host Billy Tauzin -- a former Congressman and a cancer survivor who is now the President and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA) -- speaks with her about her battle off the court with breast cancer, which she is currently fighting for the third time. The episode also includes interviews with Coach Yow's sister Deborah Yow, the athletic director at the University of Maryland, College Park, and Phyllis Greenberger, MSW, the President and CEO of the Society for Women's Health Research.

In this month's show, Couch Yow offers some insight into her attitude: "If life kicks you, make sure it kicks you forward." She adds, "Cancer is an example. I have 100 percent control over how I will choose to respond, and I've been fortunate because I've been able to learn how to deal with a lot of pressures on the court. It's definitely helped me."

Previous episodes of Sharing Miracles have featured former White House Press Secretary Tony Snow, who is battling colon cancer; syndicated television talk show host Montel Williams, a multiple sclerosis sufferer; and Telemundo personality Mayte Prida. Future programs will highli
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Susan G. Komen for the Cure Sharing Grassroots Advocacy Knowledge With International Representatives in Intensive Dallas Training Session
2. Sharing Miracles Television Program Extends Reach Across America: First Episode Features Former White House Press Secretary Tony Snow
3. Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop Drive-Through Mastectomies
4. Technique enhances digital television viewing for visually-impaired
5. Natural Nutrition Launches Long Life Cocktail with International Television Ad Campaign
6. Study links hypertension in obese children to television viewing
7. Smilebox and Lifetime Television Promote Breast Cancer Awareness With Multimedia Designs for Sending Mammogram Reminders and Celebrating Courage
8. Staffing Agency Hires Local Television News Team, Launches Broadband Network for Nurses
9. Drug Detection Kits Manufactured By IDenta Corp. Shown During French Television Broadcast (at TF1) - Product Aids French Police In Bust of 600 Kilograms Of Cocaine
10. Lumetra Program Improves Diabetes Care Among Latinos
11. OSHA Establishes a New National Emphasis Program on Silica
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...ty illnesses common, study shows , , MO...ders are common among young adults in the United S... , To reach this finding, U.S. researchers anal...9 to 25, who took part in the National Epidemiolog...The study found that 45.8 percent of the 2,188 col...
(Date:12/1/2008)...ritis Foundation announces the 2008 winners of the.... The recipients, Dr. Gerard Karsenty of the Colum...l Nussenzweig of Rockefeller University received t... in the cure and control of rheumatic diseases. ,...the development and function of the skeletal syste...
(Date:12/1/2008)...-FirstCall/ -- Senetek PLC,(OTC Bulletin Board: S...elopment of technologies that target the science o...oup AG, specialists in the fields of strategic,de...ith offices in Zurich,Bern and Geneva has publis... Research Report, available in the "Investors" sec...
(Date:12/1/2008)...er (PTSD) affects as many as one in five of all Am...pe, assault, war or terrorism. It has emotionally ...s, families. , There is no broadly accepted tre... disorder, but thanks to a Tel Aviv University res... just around the corner. , Prof. Joseph Zohar fr...
Breaking Medicine News(10 mins):Health News:Few Young Adults Seek Treatment for Psych Disorders 2Health News:Easing the stress of trauma 2
...Abuse and Alcoholism (NIAAA), a part of the U.S. N... five distinct subtypes of alcoholism by analysin...alcohol dependence. Our findings should help disp... alcoholic, notes first author Dr. Howard B. Moss,...
...ial species into another by swapping their genomes...custom-built synthetic bugs, a pioneer on genetic...mapping the human genome, said a team of his resea...enetic code of one bacterial organism into another...
...evelopment (DFID) in Britain has announced a fund... years in support of the third phase of Governmen...e (NACP III). The NACP III is a comprehensive pr...e to halt and begin to reverse the AIDS epidemic i...
...e Apple electronics stores in US cities aiming to ...olest gadget on the planet, when they go on sale F...e, web browser and music player in the palm of the...6 p.m. (2200 GMT) Friday. Late Thursday some 60 f...
Other Medicine News:Health News:Researchers Identify Five Distinct Subtypes of Alcoholism 2Health News:Researchers Identify Five Distinct Subtypes of Alcoholism 3Health News:Replacing a Genome Boosts Race to Develop Designer Bugs: Study 2Health News:Replacing a Genome Boosts Race to Develop Designer Bugs: Study 3Health News:Tech Heads Go Gaga Waiting for Apple's IPhone 2
(Date:11/26/2008)... Children whose eyes are... increased risk of developing mental illness by ea...inic study published this month in Pediatrics , th...atrics. , , The retrospective study examine...mus (misaligned eyes) and compared them with recor...
(Date:11/25/2008)...dents against expanding statin use broadly in wake....J., Nov. 25 JUPITER, a clinical t...ascular risk of healthy patients with elevated CRP...adults, according to a national poll directed at h...part in the online poll conducted by medical news ...
(Date:11/25/2008)...wire-FirstCall/ -- CardioVascular,BioTherapeutics... that it has,dosed the first patient in North Ame...trial to treat patients with severe coronary heart...nt of CORonary heart Disease) trial will include,...doses in approximately 120,patients with severe c...
(Date:11/24/2008)...vation leadership and long-term commitment to hepa...4 Schering-Plough Corpor...ate on boceprevir, its lead investigational oral h...II development. The company believes boceprevir h...n-class protease inhibitor for treating chronic he...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9The Ensign Group Successfully Graduates Troubled Nursing Home from CMS Special Focus Facility Program 12306 1The Ensign Group Successfully Graduates Troubled Nursing Home from CMS Special Focus Facility Program 12306 2The Ensign Group Successfully Graduates Troubled Nursing Home from CMS Special Focus Facility Program 12306 3Strengthening fluids with nanoparticles 3404 1Strengthening fluids with nanoparticles 3404 2Telik Announces Revised Date for Year End Financial Release Conference Call and Webcast 3401 1Tumor killing virus selectively targets diseased brain cells 12302 1Tumor killing virus selectively targets diseased brain cells 12302 2
... PALO ALTO, Calif., April 17, 2007 /PRNewswire-Fi... today of results from a,Phase 2 clinical trial of...de HCl, TLK286), carboplatin and paclitaxel in the...ung cancer. The,results include highly statistical...progression-free survival and overall survival,in ...
... - Findings Published in Blood Highlight Millenniu...rengthen the Role of VELCADE as,Foundation of Ther... CAMBRIDGE, Mass., April 17, 2007 /PRNewswire-Firs...ue of Blood show that a,team of researchers led by...iomarkers which may lead to identifying multiple,m...
Other Medicine Technology:Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 2Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 3Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 4Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 2Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 3Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 4Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 5Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 6
The IntraStent DoubleStrut Biliary Stent represents a completely new direction in stent design. The combination of parallel struts and unique cell geometry provide unparalleled performance.
The Smart Check Syphilis Device is a qualitative membrane device based immunoassay for the detection of TP (Treponema Pallidum) antibodies in whole blood/serum/plasma. For professional in vitro diagn
Bio-Quant, Inc. OneStep hCG InstaTest is an immunochromatographic assay designed for qualitative determination of human chorionic gonadotropin (hCG) in urine for early detection of pregnancy.
OneStep Midstream Urine hCG Pregnancy InstaTest is a test kit for the determination of hCG(Human Chorionic Gonadotropin) in urine specimens. This test kit is used to obtain a visual, qualitative resu
Medicine Products: